Aza Labs INC

Aza Labs INC was paid $5.04M by Medicaid between Feb 2022 and May 2023, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 60% of everything it billed.

33Billing provider infoAZA LABS INC
CHICAGO, IL 60646

33aNPI1457029449assigned 09/02/2021

33bProvider typeClinical Medical Laboratory

28Total paid$5.04M

24GClaims129,468

24DCodes billed4

24AFirst – last monthFeb 2022 – May 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#36 of 235

Median peer was paid$123K

This provider vs. median41×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	51,254	$2.00M
2023	78,214	$3.04M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	60%	43,349	17,985	$3.03M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	19%	43,295	18,017	$946K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	17%	37,751	17,885	$869K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	3.8%	5,073	2,374	$189K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSIDDIQUI, MOHAMMED (PRESIDENT)

Same official

Other billing entities under SIDDIQUI, MOHAMMED

Full network →

Provider	Location	Paid
Careplus Hospice Services, INC.	Livermore, CA	$945K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.